Paranovus Entertainment Technology Ltd.

NASDAQ:PAVS

Medical - Pharmaceuticals

Healthcare
$7.02 +20.81%

+$1.28 today

Market cap
$353.07M
Beta
-0.35
P/E (TTM)
-0.7
EPS (TTM)
-$9.07
52W Low $5.69High $148,800.00

Volume 0.16M

Average 113.44M

PAVS Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

Paranovus Entertainment Technology Ltd.NASDAQ: PAVS

Selling, General & Admin · Q2 FY2025 · quarter ended Sep 2025

Selling, general & admin grows 107.6% year over year

Q2 FY2025 selling, general & admin of $2.03M rose 107.6% year over year. Over 3 fiscal years it compounded at -66.1% a year.

Context

  • Selling, general & admin amounted to 2695.0% of revenue in FY2024.
  • Selling, general & admin increased in 0 of the last 3 fiscal years.
  • FY2024 was the lowest annual figure in the 4 fiscal years shown.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2025
$2.03M— QoQ
Last fiscal yearMar 2025
$1.93M-7.4% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+107.6%——
1 year-7.4%——
3-year CAGR-66.1%+521.7%+587.8 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2024
1.93M USD
Year-over-year change
-7.4%
4-year CAGR
-40.1%

Selling, General & Admin vs competitors

How PAVS compares with its peers on the latest reported figures

  • PAVS's FY2024 selling, general & admin of $1.93M is the lowest of the 4 companies compared; the peer median is $15.77M.
  • Its year-over-year change of -7.4% is the 2nd highest of 4, against a peer median of -15.6%.
  • Selling, general & admin amounts to 2695.0% of revenue for PAVS, versus a peer median of 37.3%.
PAVS Competitors Peer median
Selling, General & Admin for PAVS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WYHGWing Yip Food Holdings Group Limited American Depositary SharesLTM Mar 2026$19.09M -18.0%+3.9%14.4%
LSFLaird Superfood, Inc.LTM Mar 2026$15.77M -15.6%-22.8%37.3%
BOFBranchOut Food Inc.LTM Mar 2026$6.71M +42.9%+46.4%51.0%
PAVSParanovus Entertainment Technology Ltd.FY2024$1.93M -7.4%-66.1%2695.0%
Peer median (excluding PAVS) $15.77M-15.6%+3.9%37.3%

Competitors are the stored peer set for PAVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2020
Mar 2021
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
Revenue71.48M89.49M23.33M071.54K
Cost of Revenue53.31M85.78M22.92M380K442.53K
Gross Profit18.18M3.71M416.88K(380K)(370.98K)
Gross Margin25.4%4.1%1.8%—-518.6%
Research & Development1.66M1.68M1.4M00
Selling, General & Admin14.99M49.6M4.97M2.08M1.93M
Operating Expenses16.65M51.29M4.97M2.08M1.93M
Depreciation & Amortization880.88K2.19M58.75K380K380K
EBITDA2.41M(45.39M)(4.49M)(2.08M)(1.92M)
EBITDA Margin3.4%-50.7%-19.2%—-2682.4%
Operating Income1.53M(47.58M)(4.55M)(2.46M)(2.3M)
Operating Margin2.1%-53.2%-19.5%—-3213.6%
Interest Income131.9K108.4K3160156
Interest Expense111.8K85.99K72.3K39.17K261.85K
Other Income / Expenses125.62K(10.17M)22.04K(1.83M)(4.7M)
Income Before Tax1.65M(57.75M)(4.53M)(4.29M)(7M)
Pre-Tax Margin2.3%-64.5%-19.4%—-9788.2%
Income Tax Expense959.38K(3.73M)3K00
Net Income786.36K(49.19M)(71.74M)(17.67M)(7.53M)
Net Margin1.1%-55.0%-307.5%—-10519.7%
EPS (Basic)72.14(2,916.00)(1,516.10)(448.12)(10.69)
EPS (Diluted)72.14(2,916.00)(1,516.10)(448.12)(10.69)
Weighted Avg Shares10.9K16.86K47.31K39.43K704.27K
Weighted Avg Shares (Diluted)10.9K16.86K47.31K39.43K704.27K

Paranovus Entertainment Technology Ltd.

NASDAQ:PAVS

Intrinsic Alpha fair value

Locked

Current Price

$7.02

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.